Biovica International AB (publ)
Biovica International AB (publ), a biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the European Union, United States of America, and internationally. It primarily focuses on breast cancer. The company develops DiviTum TKa, a blood-based biomarker assay that measures thymidine kinase activity, which i… Read more
Biovica International AB (publ) (BIOVIC-B) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of July 2025: -0.670x
Based on the latest financial reports, Biovica International AB (publ) (BIOVIC-B) has a cash flow conversion efficiency ratio of -0.670x as of July 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-17.20 Million) by net assets (Skr25.68 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Biovica International AB (publ) - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how Biovica International AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Biovica International AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Biovica International AB (publ) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Orcoda Ltd
AU:ODA
|
-0.059x |
|
Morenzo Abadi Perkasa Tbk Pt
JK:ENZO
|
0.005x |
|
Seacera Group Bhd
KLSE:7073
|
0.000x |
|
Bitros Holding S.A
AT:MPITR
|
0.006x |
|
Nord.investments A/S
CO:NORD
|
-0.068x |
|
Equity Development Investment
JK:GSMF
|
-0.023x |
|
Patagonia Lithium Ltd
AU:PL3
|
-0.076x |
|
Prime Energy PE Ltd
TA:PRIM
|
0.056x |
Annual Cash Flow Conversion Efficiency for Biovica International AB (publ) (2015–2025)
The table below shows the annual cash flow conversion efficiency of Biovica International AB (publ) from 2015 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-04-30 | Skr43.21 Million | Skr-85.37 Million | -1.976x | -66.65% |
| 2024-04-30 | Skr96.64 Million | Skr-114.58 Million | -1.186x | -73.67% |
| 2023-04-30 | Skr138.64 Million | Skr-94.64 Million | -0.683x | -62.51% |
| 2022-04-30 | Skr124.09 Million | Skr-52.13 Million | -0.420x | -123.00% |
| 2021-04-30 | Skr182.66 Million | Skr-34.41 Million | -0.188x | +40.54% |
| 2020-04-30 | Skr78.22 Million | Skr-24.78 Million | -0.317x | +8.13% |
| 2019-04-30 | Skr52.10 Million | Skr-17.97 Million | -0.345x | -70.81% |
| 2018-04-30 | Skr73.71 Million | Skr-14.88 Million | -0.202x | -66.66% |
| 2017-04-30 | Skr91.55 Million | Skr-11.09 Million | -0.121x | +67.11% |
| 2016-04-30 | Skr25.48 Million | Skr-9.38 Million | -0.368x | -432.23% |
| 2015-04-30 | Skr8.32 Million | Skr922.00K | 0.111x | -- |